Cite
HARVARD Citation
Bullock, N. et al. (2016). Serine-arginine protein kinase 1 (SRPK1), a determinant of angiogenesis, is upregulated in prostate cancer and correlates with disease stage and invasion. Journal of clinical pathology. 69 (2), pp. 171-175. [Online].